The peptide conversation is shifting. Secretary RFK Jr. recently announced that the FDA plans to move 14 peptides from Category 2 back to Category 1 restoring FDA recognized status and making them Glutathione Injection Side Effects Risks & Safety (2026) The FDA is now reconsidering 12 peptides it previously placed in Category 2, a designation that blocks compounding pharmacies from producing them. The reasoning centers on safety concerns and limited data, but How to Give Yourself a Shot (SubQ) Olympia Pharmaceuticals PDF) The Human Tripeptide GHK Cu in Prevention of Oxidative Stress and Degenerative Conditions of Aging: Implications for Cognitive Health